Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Dose Of Dexamethasone To Be Used As An Adjuvant To Low Volume Bupivacaine Ultrasound Guided Supraclavicular Brachial Plexus Block. A Randomized Controlled Double Blinded Dose Ranging Study

NCT03043495 is registered in ClinicalTrials.gov with Eslam Ayman Mohamed Shawki as lead sponsor.

NCT NCT03043495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03043495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Dose Of Dexamethasone To Be Used As An Adjuvant To Low Volume Bupivacaine Ultrasound Guided Supraclavicular Brachial Plexus Block. A Randomized Controlled Double Blinded Dose Ranging Study
Lead sponsor
Eslam Ayman Mohamed Shawki
Phase
Phase 4
Overall status
Unknown status
Start date
October 1, 2016
Completion date
June 1, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexamethasone, supraclavicular brachial plexus block